Ifosfamide-induced Fanconi syndrome with diabetes insipidus

Ah Young Leem, Han Sang Kim, Byung Woo Yoo, Beo Deul Kang, Min Hwan Kim, Sun Young Rha, Hyo Song Kim

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Ifosfamide-induced Fanconi syndrome is a rare complication that typically occurs in young patients due to a cumulative dose of ifosfamide > 40-60 g/m2, a reduction in kidney mass, or concurrent cisplatin treatment. It is usually characterized by severe and fatal progression accompanied by type II proximal renal tubular dysfunction, as evidenced by glycosuria, proteinuria, electrolyte loss, and metabolic acidosis. Diabetes insipidus is also a rare complication of ifosfamide-induced renal disease. We herein describe a case involving a 61-year-old man who developed ifosfamide-induced Fanconi syndrome accompanied by diabetes insipidus only a few days after the first round of chemotherapy. He had no known risk factors. In addition, we briefly review the mechanisms and possible therapeutic options for this condition based on other cases in the literature. Patients who receive ifosfamide must be closely monitored for renal impairment to avoid this rare but fatal complication.

Original languageEnglish
Pages (from-to)246-249
Number of pages4
JournalKorean Journal of Internal Medicine
Issue number2
Publication statusPublished - 2014 Mar

All Science Journal Classification (ASJC) codes

  • Internal Medicine


Dive into the research topics of 'Ifosfamide-induced Fanconi syndrome with diabetes insipidus'. Together they form a unique fingerprint.

Cite this